$-11.09
(Market cap
$128 Mln
Revenue (TTM)
$80 Mln
P/E Ratio
--
P/B Ratio
0.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-12 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
2.7
-
Debt to Equity
--
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
203,492,000
10 Years Aggregate
CFO
$-252.51 Mln
EBITDA
$-231.23 Mln
Net Profit
$-296.58 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sesen Bio (SESN)
| -94.8 | -94.6 | -94.2 | -94.5 | -66.5 | -73.0 | -- |
|
BSE Sensex*
| -12.3 | -3.9 | -6.2 | -8.3 | 5.9 | 7.3 | 10.7 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Sesen Bio (SESN)
| -25.2 | -39.6 | 29.8 | -26.8 | 74.6 | -57.5 | -36.5 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sesen Bio (SESN)
|
0.6 | 128.0 | 40.0 | -19.9 | -85.6 | -12.1 | -- | 0.6 |
| 16.6 | 1,130.5 | 0.0 | -167.9 | -- | -128.7 | -- | 5.4 | |
| 25.0 | 16,164.9 | 8,837.9 | 2,614.3 | 36.5 | 45.7 | 20.1 | 2.8 | |
| 10.8 | 1,955.1 | 550.0 | 458.1 | -3.3 | 45.9 | 4.3 | 1.6 | |
| 4.1 | 1,030.1 | 4.5 | -340.2 | -518.6 | 501.4 | -- | 2.1 | |
| 14.2 | 1,888.8 | 17.2 | -102.1 | -363.1 | -19 | -- | 3.3 | |
| 12.9 | 917.4 | 106,763.2 | 5,307.0 | 5.8 | 2147 | 68.4 | 3.4 | |
| 3.0 | 641.2 | 4.0 | -198.4 | -5,037.7 | -166.3 | -- | 8.0 | |
| 16.9 | 419.9 | 4.7 | -109.7 | -- | -30.2 | -- | 1.4 | |
| 16.7 | 2,074.6 | 453.3 | -178.1 | -38.4 | -25.1 | -- | 3.2 |
Shareholding Pattern
View DetailsAbout Sesen Bio (SESN)
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a... locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts. Read more
-
Pres, CEO & Director
Dr. Thomas R. Cannell D.V.M.
-
Pres, CEO & Director
Dr. Thomas R. Cannell D.V.M.
-
Headquarters
Cambridge, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Sesen Bio (SESN)
What is the current share price of Sesen Bio Inc (SESN) Today?
The share price of Sesen Bio Inc (SESN) is $0.63 (NASDAQ) as of 07-Mar-2023 16:00 EDT. Sesen Bio Inc (SESN) has given a return of -66.49% in the last 3 years.
What is the current PB & PE ratio of Sesen Bio Inc (SESN)?
Since, TTM earnings of Sesen Bio Inc (SESN) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of Sesen Bio Inc (SESN)?
The 52-week high and low of Sesen Bio Inc (SESN) are Rs -- and Rs -- as of 06-Jun-2026.
What is the market cap of Sesen Bio Inc (SESN)?
Sesen Bio Inc (SESN) has a market capitalisation of $ 128 Mln as on 08-Mar-2023. As per SEBI classification, it is a company.
Should I invest in Sesen Bio Inc (SESN)?
Before investing in Sesen Bio Inc (SESN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.